Drug-drug interaction (“DDI”) clinical studies help identify the potential for side effects, or in some cases, reduced therapeutic efficacy, that may be caused by interactions between different drugs.

Trevi Therapeutics ((TRVI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

Company to conduct a Phase 1 Drug-Drug Interaction Study Phase 2 filing on track for Q1 2025 The DDI study is designed to evaluate the effect of a cytochrome P450 inhibitor and inducer on ALG-000184 ...

Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses ...

The Annals of Pharmacotherapy. 2012;46(5):710-717. There are several limitations to the available data. First, single-dose drug interaction studies do not permit examination of the effects of repeat ...

Fortrea collaborates with Emery Pharma for rapid rifampin impurity testing in drug-drug interaction studies, enhancing participant safety and data quality. Fortrea, a global contract research ...

In the mountains of northwestern Colombia, thousands of members of extended families carry a single genetic mutation that all but guarantees they will develop Alzheimer’s disease before age 50. For ...

MiraLAX (polyethylene glycol 3350) is an over-the-counter drug used to treat constipation in adults and certain children. MiraLAX can interact with some supplements and other medications, including ...

A label begins with highlights, a succinct, half-page summary of the information that health care practitioners most commonly refer to and view as most important (Figure 2). [4] This section provides ...